tiprankstipranks
Purple Biotech, Mor Research Applications enter oncology collaboration
The Fly

Purple Biotech, Mor Research Applications enter oncology collaboration

Purple Biotech announced a research collaboration with Mor Research Applications, the technology transfer subsidiary of Clalit Healthcare Services. The agreement provides Purple Biotech first access to early-stage oncology product candidates owned by Mor. Under this agreement, the Company will have the option to fund early development aiming both to in-license selected drug assets and to pursue their development and commercialization. Clalit is Israel’s largest Health Maintenance Organization, covering approximately half the population of Israel. Clalit serves approximately 4.8 million members and operates 14 hospitals. The research conducted at these hospitals is now potentially available to Purple Biotech for in-licensing and clinical development. Under this partnership, Purple Biotech has first right to review Mor’s pool of early-stage research projects and to select those that it wishes to explore in early development prior to in-licensing, which will carry worldwide exclusivity.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on PPBT:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles